Juno Therapeutics Inc. buy melinda
Start price
06.12.17
/
50%
€48.38
Target price
20.12.17
€55.92
Performance (%)
-17.88%
End price
20.12.17
€39.73
Summary
This prediction ended on 20.12.17 with a price of €39.73. The price of Juno Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.88%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Juno Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
Comments by melinda for this prediction
In the thread Juno Therapeutics Inc. diskutieren
2017.11.12 Die aktualisierten Daten aus Phase 1 werden 11, bei ASH Dezember 2017 vorgelegt werden.
r / r Non-Hodgkin-B-Zell - Lymphom - Krebs
Phase 1/2
(Vom Mitglied beendet)
Stopped prediction by melinda for Juno Therapeutics Inc.
Juno Therapeutics Inc.
Start price
Target price
Perf. (%)
€43.69
05.01.18
05.01.18
€56.38
17.01.18
17.01.18
39.54%
17.01.18
17.01.18
Juno Therapeutics Inc.
Start price
Target price
Perf. (%)
€27.85
14.07.16
14.07.16
€44.20
16.01.17
16.01.17
-35.22%
16.01.17
16.01.17